Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Vitamin A treatment restores vision failures arising from Leber’s hereditary optic neuropathy–linked mtDNA mutation
Cheng Ai, Huiying Li, Chunyan Wang, Yanchun Ji, Douglas C. Wallace, Junbin Qian, Yimin Zhu, Min-Xin Guan
Cheng Ai, Huiying Li, Chunyan Wang, Yanchun Ji, Douglas C. Wallace, Junbin Qian, Yimin Zhu, Min-Xin Guan
View: Text | PDF
Research Article Genetics Metabolism Ophthalmology

Vitamin A treatment restores vision failures arising from Leber’s hereditary optic neuropathy–linked mtDNA mutation

  • Text
  • PDF
Abstract

Leber hereditary optic neuropathy (LHON) is a paradigm for mitochondrial retinopathy due to mitochondrial DNA (mtDNA) mutations. However, the mechanism underlying retinal cell–specific effects of LHON-linked mtDNA mutations remains poorly understood, and there has been no effective treatment or cure for this disorder. Using a mouse model bearing an LHON-linked ND6P25L mutation, we demonstrated that the mutation caused retinal cell–specific deficiencies, especially in retinal ganglion cells (RGCs), rods, and Müller cells. Single-cell RNA sequencing revealed cell-specific dysregulation of oxidative phosphorylation and visual signaling pathways in the mutant retina. Strikingly, ND6 mutation–induced dysfunctions caused abnormal vitamin A (VA) metabolism essential for visual function. VA supplementation remarkably alleviated retinal deficiencies, including reduced fundus lesion and retinal thickness and increased numbers of RGCs, photoreceptors, and Müller cell neurites. The restoration of visual functions with VA treatment were further evidenced by correcting dysregulations of phototransduction cascade and neurotransmitter transmission and restoring electrophysiological properties. Interestingly, VA supplementation markedly rescued the abnormal mitochondrial morphologies and functions in the mutant retina. These findings provide insight into retina-specific pathophysiology of mitochondrial retinopathy arising from VA deficiency and mitochondrial dysfunction induced by mtDNA mutation and a step toward therapeutic intervention for LHON and other mitochondrial retinopathies.

Authors

Cheng Ai, Huiying Li, Chunyan Wang, Yanchun Ji, Douglas C. Wallace, Junbin Qian, Yimin Zhu, Min-Xin Guan

×

Figure 2

Cell-specific mitochondrial dysfunctions in the retina.

Options: View larger image (or click on image) Download as PowerPoint
Cell-specific mitochondrial dysfunctions in the retina.
(A) Dot plots sh...
(A) Dot plots showing the significance (−log10 P value) and overlap (percentage of differentially expressed genes; DEGs) of upregulated REACTOME pathways in the majority of cell clusters in MT retina by gene set enrichment analysis on DEGs, as compared with WT. (B) Dot plots showing the significance (–log10 P value) and overlap of downregulated REACTOME pathways in the majority of cell clusters in MT retina, as compared with WT. (C) Volcano plots showing DEGs comparing MT and WT mice in 8 retina subsets (Supplemental Figure 2A shows the remaining 6 retina subsets). Dots on the volcano plot: gray, no significant change; red, P < 0.05 and log2FC ≥ 0.5 (FC, fold change); blue, P < 0.05 and log2FC ≤ –0.5. The significantly differentially expressed OXPHOS genes were labeled. The counts of significantly up- and downregulated OXPHOS genes for each cluster were labeled. (D) Dot plots showing the average fold-change of expression of mtDNA-encoded and nDNA-encoded OXPHOS genes in each OXPHOS complex across retina subsets, comparing MT and WT mice. (E and F) Heatmap displaying expression of genes involved in the antioxidant pathway across subsets (E) and dot plot showing the quantification of average expression levels of the antioxidant pathway across subsets (F).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts